Wave Life Sciences Stock Buy Hold or Sell Recommendation
| WVE Stock | USD 10.99 0.32 2.83% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Wave Life Sciences is 'Strong Sell'. Macroaxis provides Wave Life buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding WVE positions.
Check out Wave Life Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Wave and provide practical buy, sell, or hold advice based on investors' constraints. Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Wave |
Execute Wave Life Buy or Sell Advice
The Wave recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Wave Life Sciences. Macroaxis does not own or have any residual interests in Wave Life Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Wave Life's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Wave Life Trading Alerts and Improvement Suggestions
| Wave Life Sciences generated a negative expected return over the last 90 days | |
| Wave Life Sciences has high historical volatility and very poor performance | |
| The company reported the last year's revenue of 113.31 M. Reported Net Loss for the year was (57.51 M) with loss before taxes, overhead, and interest of (95.5 M). | |
| Wave Life Sciences has about 148.16 M in cash with (19.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. | |
| Over 79.0% of the company outstanding shares are owned by institutional investors |
Wave Life Returns Distribution Density
The distribution of Wave Life's historical returns is an attempt to chart the uncertainty of Wave Life's future price movements. The chart of the probability distribution of Wave Life daily returns describes the distribution of returns around its average expected value. We use Wave Life Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Wave Life returns is essential to provide solid investment advice for Wave Life.
| Mean Return | -0.43 | Value At Risk | -8.05 | Potential Upside | 7.43 | Standard Deviation | 4.24 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Wave Life historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Wave Life Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Wave Life or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Wave Life's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Wave stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.45 | |
β | Beta against Dow Jones | 0.18 | |
σ | Overall volatility | 4.24 | |
Ir | Information ratio | -0.11 |
Wave Life Volatility Alert
Wave Life Sciences exhibits very low volatility with skewness of 0.2 and kurtosis of 0.93. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Wave Life's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Wave Life's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Wave Life Fundamentals Vs Peers
Comparing Wave Life's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Wave Life's direct or indirect competition across all of the common fundamentals between Wave Life and the related equities. This way, we can detect undervalued stocks with similar characteristics as Wave Life or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Wave Life's fundamental indicators could also be used in its relative valuation, which is a method of valuing Wave Life by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Wave Life to competition |
| Fundamentals | Wave Life | Peer Average |
| Return On Equity | -2.44 | -0.31 |
| Return On Asset | -0.34 | -0.14 |
| Profit Margin | (2.66) % | (1.27) % |
| Operating Margin | 8.33 % | (5.51) % |
| Current Valuation | 1.44 B | 16.62 B |
| Shares Outstanding | 152.52 M | 571.82 M |
| Shares Owned By Insiders | 15.03 % | 10.09 % |
| Shares Owned By Institutions | 79.40 % | 39.21 % |
| Number Of Shares Shorted | 8.21 M | 4.71 M |
| Price To Earning | (6.50) X | 28.72 X |
| Price To Book | 12.18 X | 9.51 X |
| Price To Sales | 32.18 X | 11.42 X |
| Revenue | 113.31 M | 9.43 B |
| Gross Profit | (95.5 M) | 27.38 B |
| EBITDA | (58.79 M) | 3.9 B |
| Net Income | (57.51 M) | 570.98 M |
| Cash And Equivalents | 148.16 M | 2.7 B |
| Cash Per Share | 1.71 X | 5.01 X |
| Total Debt | 32.12 M | 5.32 B |
| Debt To Equity | 1.02 % | 48.70 % |
| Current Ratio | 2.50 X | 2.16 X |
| Book Value Per Share | 0.95 X | 1.93 K |
| Cash Flow From Operations | (19.43 M) | 971.22 M |
| Short Ratio | 7.85 X | 4.00 X |
| Earnings Per Share | (1.12) X | 3.12 X |
| Target Price | 22.3 | |
| Number Of Employees | 266 | 18.84 K |
| Beta | -1.21 | -0.15 |
| Market Capitalization | 1.73 B | 19.03 B |
| Total Asset | 274.95 M | 29.47 B |
| Retained Earnings | (1.02 B) | 9.33 B |
| Working Capital | 48.93 M | 1.48 B |
| Current Asset | 161.38 M | 9.34 B |
Note: Acquisition by Chandra Vargeese of 50000 shares of Wave Life at 10.48 subject to Rule 16b-3 [view details]
Wave Life Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Wave . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Wave Life Buy or Sell Advice
When is the right time to buy or sell Wave Life Sciences? Buying financial instruments such as Wave Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Wave Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Long/short ETFs Thematic Idea Now
Long/short ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Long/short ETFs theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long/short ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Wave Life Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.